Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter ended in June - Earnings Summary

Reviva Pharmaceuticals Holdings

14/08/2023 21:46

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ  reported a
quarterly adjusted loss of 55 cents​​ per share for the quarter
ended in June. The mean expectation of five analysts for the
quarter was for a loss of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Reviva Pharmaceuticals Holdings, Inc.'s reported EPS for
the
quarter was a loss of 55 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Reviva Pharmaceuticals Holdings, Inc. shares had fallen
by 29.5%
this quarter and lost 2.8% so far this year.
    * The company reported a quarterly loss of $12.44 million.
    * Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 08:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.28          -0.55          Missed
 Mar. 31 2023      -0.32          -0.30          Beat
 Dec. 31 2022      -0.22          -0.38          Missed
 Sep. 30 2022      -0.29          -0.18          Beat